Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1716

1.

Prediction of treatment outcome and relapse in inflammatory bowel disease.

Kato J, Yoshida T, Hiraoka S.

Expert Rev Clin Immunol. 2019 Mar 15:1-11. doi: 10.1080/1744666X.2019.1593140. [Epub ahead of print]

PMID:
30873890
2.

miR-7977 inhibits the Hippo-YAP signaling pathway in bone marrow mesenchymal stromal cells.

Yoshida M, Horiguchi H, Kikuchi S, Iyama S, Ikeda H, Goto A, Kawano Y, Murase K, Takada K, Miyanishi K, Kato J, Kobune M.

PLoS One. 2019 Mar 5;14(3):e0213220. doi: 10.1371/journal.pone.0213220. eCollection 2019.

3.

PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells.

Mashimo M, Bu X, Aoyama K, Kato J, Ishiwata-Endo H, Stevens LA, Kasamatsu A, Wolfe LA, Toro C, Adams D, Markello T, Gahl WA, Moss J.

JCI Insight. 2019 Feb 21;4(4). pii: 124519. doi: 10.1172/jci.insight.124519. eCollection 2019 Feb 21.

4.

Docetaxel therapy for classic Kaposi's sarcoma.

Hosokawa Y, Kato J, Hida T, Horimoto K, Sato S, Sawada M, Sasaki H, Matsui Y, Handa T, Uhara H.

Asia Pac J Clin Oncol. 2019 Feb 21. doi: 10.1111/ajco.13139. [Epub ahead of print] No abstract available.

PMID:
30790461
5.

Efficacy of combined radiotherapy and anti-programmed death 1 therapy in acral and mucosal melanoma.

Kato J, Hida T, Someya M, Sato S, Sawada M, Horimoto K, Fujioka M, Minowa T, Matsui Y, Tsuchiya T, Kitagawa M, Nakata K, Sakata KI, Torigoe T, Uhara H.

J Dermatol. 2019 Feb 13. doi: 10.1111/1346-8138.14805. [Epub ahead of print]

PMID:
30758859
6.

[Bacteriocidal effects of introducing copper products on highly touched areas in hematology ward].

Mori T, Kikuchi T, Sakurai M, Kato J, Koda Y, Abe R, Sumiya C, Yamazaki R, Sugita K, Hasegawa N, Okamoto S.

Rinsho Ketsueki. 2019;60(1):3-6. doi: 10.11406/rinketsu.60.3. Japanese.

PMID:
30726821
7.

Long-term outcomes of patients with Crohn's disease who received infliximab or adalimumab as the first-line biologics.

Inokuchi T, Takahashi S, Hiraoka S, Toyokawa T, Takagi S, Takemoto K, Miyaike J, Fujimoto T, Higashi R, Morito Y, Nawa T, Suzuki S, Nishimura M, Inoue M, Kato J, Okada H.

J Gastroenterol Hepatol. 2019 Feb 6. doi: 10.1111/jgh.14624. [Epub ahead of print]

PMID:
30724387
8.

Trastuzumab-Based Combination Chemotherapy in Patients with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Carcinoma ex Pleomorphic Adenoma.

Arihara Y, Murase K, Takada K, Hayasaka N, Miura S, Miyanishi K, Kobune M, Kurose M, Akiyama Y, Sugita S, Kato J.

Case Rep Oncol. 2018 Dec 11;11(3):835-841. doi: 10.1159/000495344. eCollection 2018 Sep-Dec.

9.

Renal dysfunction and anemia associated with long-term imatinib treatment in patients with chronic myelogenous leukemia.

Sakurai M, Kikuchi T, Karigane D, Kasahara H, Matsuki E, Hashida R, Yamane Y, Abe R, Koda Y, Toyama T, Kato J, Shimizu T, Yokoyama Y, Suzuki S, Nakamura T, Okamoto S, Mori T.

Int J Hematol. 2019 Mar;109(3):292-298. doi: 10.1007/s12185-019-02596-z. Epub 2019 Jan 24.

PMID:
30680668
10.

Successful Steroid Therapy for Lipoid Pneumonia Developing After Allogeneic Hematopoietic Stem Cell Transplant: A Case Report.

Sakurai M, Kato J, Toyama T, Hashida R, Yamane Y, Abe R, Koda Y, Kohashi S, Kikuchi T, Hayashi Y, Nukaga S, Ueda S, Fukunaga K, Okamoto S, Mori T.

Transplant Proc. 2018 Dec;50(10):4096-4098. doi: 10.1016/j.transproceed.2018.09.004. Epub 2018 Sep 8.

PMID:
30577323
11.

New radiological findings and radiculomegaly in oculofaciocardiodental syndrome with a novel BCOR mutation: A case report.

Kato J, Kushima K, Kushima F.

Medicine (Baltimore). 2018 Dec;97(49):e13444. doi: 10.1097/MD.0000000000013444.

12.

Simultaneous enzymatic saccharification and comminution for the valorization of lignocellulosic biomass toward natural products.

Navarro RR, Otsuka Y, Nojiri M, Ishizuka S, Nakamura M, Shikinaka K, Matsuo K, Sasaki K, Sasaki K, Kimbara K, Nakashimada Y, Kato J.

BMC Biotechnol. 2018 Dec 12;18(1):79. doi: 10.1186/s12896-018-0487-1.

13.

The novel latex agglutination turbidimetric immunoassay system for simultaneous measurements of calprotectin and hemoglobin in feces.

Hiraoka S, Takashima S, Inokuchi T, Nakarai A, Takahara M, Harada K, Seki Y, Watanabe K, Kato J, Okada H.

Intest Res. 2018 Dec 14. doi: 10.5217/ir.2018.00086. [Epub ahead of print]

14.

Maternally inherited diabetes and deafness complicated by mesangial galactose-deficient IgA1 deposits: a case report.

Sugai K, Ueda H, Morimoto K, Tanaka M, Takahashi D, Nakashima A, Kato J, Takahashi H, Yamaguchi Y, Kawamura T, Hanaoka K, Miyazaki Y, Yokoo T.

BMC Nephrol. 2018 Dec 10;19(1):350. doi: 10.1186/s12882-018-1152-6.

15.

Enhanced sensitivity to cholera toxin in female ADP-ribosylarginine hydrolase (ARH1)-deficient mice.

Watanabe K, Kato J, Zhu J, Oda H, Ishiwata-Endo H, Moss J.

PLoS One. 2018 Nov 30;13(11):e0207693. doi: 10.1371/journal.pone.0207693. eCollection 2018.

16.

Effects of a cyborg-type robot suit HAL on cardiopulmonary burden during exercise in normal subjects.

Pak YJ, Koike A, Watanabe H, Terai T, Kubota H, Takahashi M, Konno H, Kato J, Nishi I, Sato A, Kawamoto H, Aonuma K, Ieda M, Sankai Y.

Eur J Appl Physiol. 2019 Feb;119(2):487-493. doi: 10.1007/s00421-018-4040-7. Epub 2018 Nov 29.

PMID:
30499055
17.

An alternative genome-integrated method for undomesticated Bacillus subtilis and related species.

Mahipant G, Kato J, Kataoka N, Vangnai AS.

J Gen Appl Microbiol. 2018 Nov 27. doi: 10.2323/jgam.2018.06.001. [Epub ahead of print]

18.

Nodular gastritis in association with gastric cancer development before and after Helicobacter pylori eradication.

Nishikawa I, Kato J, Terasoma S, Matsutani H, Tamaki H, Tamaki T, Kuwashima F, Nakata H, Tomeki T, Matsunaka H, Ibata Y, Yamashita Y, Maekita T, Higashi K, Ichinose M.

JGH Open. 2018 Mar 25;2(3):80-86. doi: 10.1002/jgh3.12049. eCollection 2018 Jun.

19.

Blood biomarkers reflect integration of severity and extent of endoscopic inflammation in ulcerative colitis.

Uchihara M, Kato J, Tsuda S, Yoshida T, Maekita T, Iguchi M, Kitano M.

JGH Open. 2017 Nov 1;1(3):98-104. doi: 10.1002/jgh3.12017. eCollection 2017 Nov.

20.

Role of a TRIM72 ADP-ribosylation cycle in myocardial injury and membrane repair.

Ishiwata-Endo H, Kato J, Tonouchi A, Chung YW, Sun J, Stevens LA, Zhu J, Aponte AM, Springer DA, San H, Takeda K, Yu ZX, Hoffmann V, Murphy E, Moss J.

JCI Insight. 2018 Nov 15;3(22). pii: 97898. doi: 10.1172/jci.insight.97898.

Supplemental Content

Loading ...
Support Center